The results showed that HCC exosome-reprogrammed mBMDNs could upregulate the expression of PD-1, but suppress the expression of CD69, and the production of IFN-γ and TNF-α in CD8+ T cells (Figure 4A) and CD4+ T cells (Figure S5B). The gene discussed is CD4; the disease is hepatocellular carcinoma.